Comparative neuromuscular blocking effects of vecuronium, pancuronium, Org 6368 and suxamethonium in the anaesthetized domestic pig.

The neuromuscular blocking and cardiovascular effects of three competitive neuromuscular blocking drugs, vecuronium, pancuronium and Org 6368, and the depolarizing drug suxamethonium, have been evaluated in the anaesthetized domestic pig. Both the relative time-course and the order of potency of the drugs agreed well with published data in man. In addition, the cardiovascular side-effects of pancuronium and Org 6368 were identified readily. These preliminary results suggest that the pig may provide more reliable neuromuscular blocking time-course data than does the more commonly utilized cat model.

[1]  R. Hughes.  Experimental and clinical evaluation of neuromuscular blocking agents. , 1984, Journal of pharmacological methods.

[2]  I. Squire,et al.  Neuromuscular blocking and autonomic effects of vecuronium and atracurium in the anaesthetized cat. , 1983, British journal of anaesthesia.

[3]  I. G. Marshall,et al.  Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat. , 1983, British journal of anaesthesia.

[4]  P. Lilleaasen,et al.  Dose-response relation for atracurium, ORG NC 45 and pancuronium. , 1982, British journal of anaesthesia.

[5]  N. Krieg,et al.  Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man. , 1981, British journal of anaesthesia.

[6]  J. Ojewole,et al.  Comparison of the autonomic effects of some currently-used neuromuscular blocking agents [proceedings]. , 1979, British journal of pharmacology.

[7]  J. McGrath,et al.  SYMPATHOMIMETIC EFFECTS OF PANCURONIUM BROMIDE ON THE CARDIOVASCULAR SYSTEM OF THE PITHED RAT: A COMPARISON WITH THE EFFECTS OF DRUGS BLOCKING THE NEURONAL UPTAKE OF NORADRENALINE , 1978, British journal of pharmacology.

[8]  J. P. Payne,et al.  Studies on fazadinium bromide (AH 8165): A new non-depolarizing neuromuscular blocking agent , 1976, Canadian Anaesthetists' Society journal.

[9]  M. F. Sugrue,et al.  On the pharmacology of Org 6368 (2β, 16β ‐ dipiperidino ‐ 5α ‐ androstan ‐ 3α ‐ ol acetate dimethobromide), a new steroidal neuromuscular blocking agent , 1975 .

[10]  W. Baird.  Initial studies in man with a new myoneural blocking agent (ORG.6368). , 1974, British Journal of Anaesthesia.

[11]  J. Norman,et al.  Some effects of the steroidal muscle relaxant, dacuronium bromide, in anaesthetized patients. , 1971, British journal of anaesthesia.

[12]  I. Bonta,et al.  Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blockade of cardiac muscarinic receptors. , 1970, European journal of pharmacology.

[13]  I. Bonta,et al.  Different potency of pancuronium bromide on two types of skeletal muscle. , 1968, European journal of pharmacology.

[14]  K. J. Child,et al.  Neuromuscular blocking activities of some steroidal mono and bis-quaternary ammonium compounds with special reference to NN'-dimethylconessine. , 1968, British journal of pharmacology and chemotherapy.

[15]  W. Paton,et al.  The action of d‐tubocurarine and of decamethonium on respiratory and other muscles in the cat , 1951, The Journal of physiology.

[16]  J. Pickering,et al.  The Action of , 1922 .